Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107868087A details a rhodium-catalyzed method for pyrroloindole derivatives, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis for indolocyclopentanes. High yield, scalable process for anticancer drug development. Reliable supply chain partner.
Patent CN112679498A reveals a high-purity route for beta-lactamase inhibitors, offering significant cost and supply chain advantages for API manufacturers.
Advanced synthesis method for Oseltamivir phosphate isomer impurity ensuring quality control. Reliable supplier for pharmaceutical intermediates with cost reduction.
Patent CN110452150A reveals mild chiral phosphoric acid catalysis. Enables cost reduction in fine chemical intermediates manufacturing with high enantioselectivity.
Discover a novel method for preparing chiral spiro indolone compounds using cinchona alkaloid catalysts. High yield, mild conditions, and scalable pharma intermediate production.
Patent CN105669522B reveals metal-free visible light synthesis for high-purity indolinones offering substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN103665036B details novel chiral ligands enabling high-purity pharmaceutical intermediate manufacturing with significant cost reduction and supply chain reliability.
Patent CN103274917B reveals a novel copper-catalyzed route for benzil derivatives, offering significant cost reduction and mild conditions for pharmaceutical intermediate manufacturing.
Novel method uses glucose as carbon source for triazole synthesis. Offers mild conditions and high efficiency for reliable pharmaceutical intermediate supply chains.
Patent CN113735867B reveals high-yield chiral synthesis. Enables cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles with high enantioselectivity for anticancer drug development and pharmaceutical intermediates.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Patent CN115785122A details a novel Sc(OTf)3-catalyzed synthesis of indole-derived piperidines with high cytotoxicity, offering a scalable route for reliable pharmaceutical intermediate suppliers.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity for asymmetric catalysis and cost-effective manufacturing.
Novel N-N axis chiral ligand synthesis via organocatalysis. High enantioselectivity for pharma intermediates. Cost-effective scalable route for complex molecule manufacturing.
Patent CN107698590B details a novel asymmetric [3+2] cyclization for chiral carbocyclic purine nucleosides, offering high yields and enantioselectivity for reliable pharmaceutical intermediate supply.
Patent CN107382769B reveals a low-cost synthesis route for trifluoromethyl azides. This method enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Novel radical cyclization method for 2-CF3 cyclopentenones. Efficient, mild conditions, scalable for API intermediates and fine chemicals.